CTLT
Catalent Inc
Price:  
54.65 
USD
Volume:  
1,342,524.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Catalent EV/EBITDA

-97.5%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Catalent Inc (CTLT) is 64.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Catalent's latest enterprise value is 14,708.01 mil USD. Catalent's TTM EBITDA according to its financial statements is 227.00 mil USD. Dividing these 2 quantities gives us the above Catalent EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 8.1x - 9.9x 9.5x
Forward P/E multiples 11.6x - 18.9x 13.6x
Fair Price (16.49) - 34.51 1.38
Upside -130.2% - -36.9% -97.5%
54.65 USD
Stock Price
1.38 USD
Fair Price

Catalent EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 64.79
2024-05-22 65.05
2024-05-21 65.04
2024-05-20 65.07
2024-05-17 65.37
2024-05-16 65.27
2024-05-15 65.56
2024-05-14 65.49
2024-05-13 65.71
2024-05-10 65.72
2024-05-09 65.85
2024-05-08 66.03
2024-05-07 66.29
2024-05-06 66.16
2024-05-03 66.27
2024-05-02 66.14
2024-05-01 65.87
2024-04-30 65.75
2024-04-29 66.11
2024-04-26 65.81
2024-04-25 65.71
2024-04-24 65.83
2024-04-23 65.89
2024-04-22 65.91
2024-04-19 65.45
2024-04-18 65.71
2024-04-17 65.84
2024-04-16 65.69
2024-04-15 65.93
2024-04-12 66.11
2024-04-11 66.60
2024-04-10 66.68
2024-04-09 66.67
2024-04-08 66.42
2024-04-05 66.47
2024-04-04 66.63
2024-04-03 66.41
2024-04-02 66.23
2024-04-01 66.18
2024-03-28 66.23
2024-03-27 66.25
2024-03-26 66.08
2024-03-25 66.19
2024-03-22 65.70
2024-03-21 65.75
2024-03-20 65.77
2024-03-19 65.83
2024-03-18 65.84
2024-03-15 66.04
2024-03-14 66.43